Skip to main content

CervoMed Inc.

CRVO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001053691

No open-market purchases or sales by CervoMed Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $5.42M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding CervoMed Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of CRVO: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders491480
Shares1.49M41.6K2.28M+839.1K (+58.1%)
Value$3.46M$97.3K$20.9M+$17.5M (+521.3%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (11)

Institutions that held CervoMed Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to CRVO in Q1 2025
InstitutionSharesValue% of portfolio
AWM Investment Company, Inc.863,200$7.90M1.09%
Nuveen, LLC34,099$312.0K0.00%
Citizens Financial Group Inc26,677$244.1K0.00%
Avantax Advisory Services, Inc.25,984$237.8K0.00%
AQR Capital Management LLC24,846$227.3K0.00%
Bank of New York Mellon Corp12,028$110.1K0.00%
HighTower Advisors, LLC11,344$103.8K0.00%
Police & Firemen's Retirement System of New Jersey2,099$19.2K0.00%
Caitong International Asset Management Co., Ltd1,609$14.7K0.01%
EverSource Wealth Advisors, LLC36$3290.00%
True Wealth Design, LLC4$370.00%

Sold out (11)

Institutions that held CervoMed Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of CRVO in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Woodline Partners LP74,852$175.2K
Qube Research & Technologies Ltd28,021$65.6K
Millennium Management LLC18,463$43.2K
Goldman Sachs Group Inc13,750$32.2K
Mariner, LLC12,937$30.3K
HRT Financial LP12,987$30.0K
DRW Securities, LLC12,708$29.7K
Virtu Financial LLC11,224$26.0K
Citadel Advisors LLC10,811$25.3K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC2$4
Covestor Ltd190$0

Not filed for Q1 2025 yet (1)

Institutions that held CervoMed Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRVO in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC41,569$97.3K